| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.24 |
4e-06 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.25 |
2e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.5 |
5e-05 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |
| mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |